Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings

Abstract

Background: The core motive of pharmacovigilance is the detection and prevention of adverse drug reactions (ADRs), to improve the risk-benefit balance of the drug. However, the causality assessment of ADRs remains a major challenge among clinicians, and none of the available tools of causality assessment used for assessing ADRs have been universally accepted. Objective: To provide an up-to-date overview of the different causality assessment tools. Methods: We conducted electronic searches in MEDLINE, EMBASE, and the Cochrane database. The eligibility of each tool was screened by three reviewers. Each eligible tool was then scrutinized for its domains (the reported specific set of questions/areas used for calculating the likelihood of cause-and-effect relation of an ADR) to discover the most comprehensive tool. Finally, we subjectively assessed the tool's ease-of-use in a Canadian, Indian, Hungarian, and Brazilian clinical context. Results: Twenty-one eligible causality assessment tools were retrieved. Naranjo's tool and De Boer's tool appeared the most comprehensive among all the tools, covering 10 domains each. Regarding "ease-of-use" in a clinical setting, we judged that many tools were hard to implement in a clinical context because of their complexity and/or lengthiness. Naranjo's tool, Jones's tool, Danan and Benichou's tool, and Hsu and Stoll's tool appeared to be the easiest to implement into various clinical contexts. Conclusion: Among the many tools identified, 1981 Naranjo's scale remains the most comprehensive and easy to use for performing causality assessment of ADRs. Upcoming analysis should compare the performance of each ADR tool in clinical settings.

Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment

“…The Causality assessment (CA) in PV is a process well described and based on different methodologies [ 68 , 69 , 70 ]. For vaccines, in the 2019 update of the CA of an adverse event following immunization (AEFI), WHO provided a user manual for persons implicated in immunization programmes [ 71 ].…”

Omeprazole was safely reused in a rhabdomyolysis patient associated with proton pump inhibitors: A case report

“…The possibility of rhabdomyolysis associated with PPIs was considered. The Naranjo adverse drug reaction (ADR) probability scale was used to determine causality 10 . Naranjo ADR scores were found to be 3 (probable) for atorvastatin and 3 (probable) for PPIs.…”

Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions

“…Various methods have been proposed to evaluate the causal relationship between an adverse event and the medication taken by the patient [ 45 ]. The algorithm methods are primarily based on decision trees or consecutive answers to specific questions, resulting in a sum of scores [ 46 ]. Algorithms give structured and standardized methods of assessment in a systematic approach to evaluating causal associations in adverse drug reactions based on parameters such as time to onset of the adverse event or temporal sequence, previous adverse drug reaction history, and response to drug withdrawal or rechallenge.…”